Description
PF-06939999 is a SAM-competitve inhibitor of PRMT5.
| Product Unit Size | Cost | Quantity | Stock |
|---|
PF-06939999 is a SAM-competitve inhibitor of PRMT5.
| Cas No. | 2159123-14-3 |
|---|---|
| Purity | ≥98% |
| Formula | C22H23F3N4O3 |
| Formula Wt. | 448.45 |
| IUPAC Name | (1S,2S,3S,5R)-3-[[6-(difluoromethyl)-5-fluoro-1,2,3,4-tetrahydroisoquinolin-8-yl]oxy]-5-(4-methylpyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol |
| Synonym | PF06939999; PRMT5-IN-3 |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Jensen-Pergakes K, Tatlock J, Maegley K, et al. SAM-competitive PRMT5 inhibitor PF-06939999 demonstrates antitumor activity in splicing dysregulated NSCLC with decreased liability of drug resistance. Mol Cancer Ther. 2022 Jan;21(1):3-15. PMID 34737197
Alkaline phosphatase substrate used to quantify...
Pyrimidine nucleoside base, pairs with adenosin...
Water-soluble cortisol derivative; glucocortico...
Methimazole prodrug; thyroid peroxidase inhibit...
RF-amide peptide; potential GPR147 agonist, pot...
Impurity of rapamycin
Pan inhibitor of ALK.
NSAID; PG synthetase inhibitor.
Isoquinoline alkaloid found in a variety of pla...
Peptide produced in tomato leaves; potential ca...
NSAID; COX-1/2 inhibitor.
Viral neuraminidase inhibitor, potential MAO-A ...
Anthracycline, DNA intercalator; topoisomerase ...
PDEδ inhibitor.
Peptide used to measure in vitro calcineurin ac...
FIASMA, μOR agonist, potential HCN channel blo...
mTOR activator.
Semi-synthetic avermectin; GABA potentiator.
Statin; HMG-CoA reductase inhibitor, potential ...
Bisphosphonate.